» Articles » PMID: 33180907

Structural Gray and White Matter Differences in Patients With Type 1 Diabetes and Impaired Awareness of Hypoglycemia

Overview
Specialty Endocrinology
Date 2020 Nov 12
PMID 33180907
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Type 1 diabetes (T1D) is associated with an increased risk of cognitive decline, where severe hypoglycemia (SH) and impaired awareness of hypoglycemia (IAH) may play a role. While there is evidence of a possible association between IAH and brain damage, the potential brain changes remain poorly characterized by magnetic resonance imaging (MRI).

Objective: To investigate whether there are structural brain differences in a group of T1D patients with IAH compared with normal awareness of hypoglycemia (NAH).

Design: General practice, population-based, cross-sectional study (July 2018 to July 2019).

Setting: Endocrinology Department, Hospital Santa Creu i Sant Pau.

Participants: A total of 40 T1D patients (20 each with IAH and NAH) matched for age, sex, T1D duration, and education level.

Main Outcome Measures: Using different neuroimaging techniques, we compared whole-brain gray matter (GM) and white matter (WM) differences. We used voxel-based morphometry and cortical surface area analysis methods to assess GM differences, and fractional anisotropy (FA) to assess WM differences.

Results: Compared with patients with T1D-NAH, patients with T1D-IAH had reduced GM volumes and cortical surface areas, especially in frontal and parietal regions (P < 0.05 corrected), and also showed reduced FA values in major WM tracts. The observed MRI differences correlated with both SH frequency and IAH severity.

Conclusions: MRI for patients with T1D show that IAH is associated with brain changes involving both GM and WM. Further research is needed to elucidate whether the observed differences are a consequence of increased SH episode frequency and increased IAH severity.

Citing Articles

Retinal Microperimetry as a Novel Tool for Early Detection of Subclinical Cognitive Dysfunction and Brain Damage in Type 1 Diabetes: A Pilot Study.

Mateu-Salat M, Stanton-Yonge N, Santalo F, Vela J, Cascajosa J, Perez E Endocrinol Diabetes Metab. 2024; 8(1):e70018.

PMID: 39707866 PMC: 11662260. DOI: 10.1002/edm2.70018.


Exploratory Multisite MR Spectroscopic Imaging Shows White Matter Neuroaxonal Loss Associated with Complications of Type 1 Diabetes in Children.

Cai L, Tanase C, Anderson A, Patel N, Lee C, Jones R AJNR Am J Neuroradiol. 2023; 44(7):820-827.

PMID: 37263786 PMC: 10337627. DOI: 10.3174/ajnr.A7895.


Prevalence and contributing factors of impaired awareness of hypoglycemia in patients with type 2 diabetes: a meta-analysis.

Li X, Kan Y, Liu H, Pang J, He Y, Liu L Acta Diabetol. 2023; 60(9):1155-1169.

PMID: 37199797 DOI: 10.1007/s00592-023-02102-2.